Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-09-17FDA Approved: LISINOPRIL — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for lisinopril by Exelan Pharmaceuticals Inc., related to a generic lisinopril product. This ref…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Spinal Cord Stimulation to Treat Hypertension [NA]
Clinical trial update on using spinal cord stimulation to treat hypertension; study completed with results posted in 2020.
-
FDA approval · 2020-09-15FDA Approved: LISINOPRIL — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's generic lisinopril (LISINOPRIL) under an original ANDA for the same indications as the brand. Indications i…
-
FDA approval · 2020-09-08FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for amlodipine and benazepril hydrochloride, enabling marketing of the combination antihypertensive …
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Manidipine Versus Amlodipine in Patients With Hypertension [Phase 4]
Phase 4 trial comparing manidipine to amlodipine in hypertension was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-09-03Clinical Trial Update: Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes [Phase 4]
Phase 4 study investigating losartan-based therapy in hypertensive patients, with and without diabetes, has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine [Phase 4]
Phase 4 trial update on fixed-dose combinations of perindopril/amlodipine and perindopril/indapamide/amlodipine for newly diagnosed and unco…
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension [Phase 2]
Phase 2 trial of IW-1973, an sGC stimulator, in stable type 2 diabetes with hypertension completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy [Phase 3]
Phase 3 trial comparing candesartan–amlodipine combination therapy to candesartan alone in hypertensive patients not adequately controlled o…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine [Phase 3]
A Phase 3 trial comparing urapidil versus nicardipine for hypertension associated with severe preeclampsia was terminated.
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's [Phase 4]
Phase 4 trial update evaluating antihypertensives in individuals at risk for Alzheimer's disease; study completed with results posted.
-
FDA approval · 2020-08-20FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE HCT (amlodipine/valsartan/hydrochlorothiazide) from Novartis Pharmaceuticals Corporation…
-
FDA approval · 2020-08-20FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
The FDA granted approval of a supplemental application for ZESTORETIC (lisinopril/hydrochlorothiazide) submitted by Almatica Pharma Inc.
-
FDA approval · 2020-08-20FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for the combination drug candesartan cilexetil and hydrochlorothiazide by ANI Pharmaceuticals, u…
-
FDA approval · 2020-08-20FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for the combination drug benazepril hydrochloride and hydrochlorothiazide, manufactured by Padag…
-
FDA label_change · 2020-08-20FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Lisinopril and Hydrochlorothiazide from Aurobindo Pharma Limited.
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Hydrochlorothiazide from Aurobindo Pharma Limited. The decision updates the approved generic pro…
-
FDA approval · 2020-08-20FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVALIDE (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC. The product i…
-
FDA approval · 2020-08-20FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) from Bausch Health US, LLC.
-
FDA approval · 2020-08-20FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for the combination drug fosinopril sodium and hydrochlorothiazide submitted by CIPLA USA INC.
-
FDA approval · 2020-08-20FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil/amlodipine besylate/hydrochlorothiazide) from Cosette Pharma…
-
FDA approval · 2020-08-20FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination spironolactone and hydrochlorothiazide.
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for hydrochlorothiazide from Accord Healthcare Inc., approving changes under the supplemental submis…
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved a supplemental application for hydrochlorothiazide from ScieGen Pharmaceuticals, Inc., under an ANDA.
-
FDA approval · 2020-08-20FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare LLC)
The FDA approved a supplemental application for a generic fixed-dose combination tablet of lisinopril and hydrochlorothiazide by Solco Healt…